Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000839028 | SCV000980907 | likely benign | not provided | 2020-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000839028 | SCV002429006 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434041 | SCV002751080 | likely benign | Cardiovascular phenotype | 2019-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001700313 | SCV005039877 | likely benign | not specified | 2024-03-17 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000839028 | SCV001744685 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001700313 | SCV001918215 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000839028 | SCV001970296 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004538150 | SCV004739105 | likely benign | ALPK3-related disorder | 2020-08-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |